Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial

AIMS: Therapy with i.v. iron in patients with chronic heart failure (CHF) and iron deficiency (ID) improves symptoms, functional capacity, and quality of life. We sought to investigate whether these beneficial outcomes are independent of anaemia. METHODS AND RESULTS: FAIR-HF randomized 459 patients...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Filippatos, Gerasimos, Farmakis, Dimitrios, Colet, Josep Comin, Dickstein, Kenneth, Lüscher, Thomas F., Willenheimer, Ronnie, Parissis, John, Gaudesius, Giedrius, Mori, Claudio, von Eisenhart Rothe, Barbara, Greenlaw, Nicola, Ford, Ian, Ponikowski, Piotr, Anker, Stefan D.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2013
Assuntos:
Comorbidity
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3806282/
https://ncbi.nlm.nih.gov/pubmed/23787722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurjhf/hft099
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares